Summer Budget Travel Tips from Gadling

AOL Money & Finance

Cramer on BloggingStocks: A bevy of bank offerings

TheStreet.com's Jim Cramer says we should closely monitor the situation as more banks raise capital with equity.

What really did happen Friday? I keep thinking about this because, surely, if you saw how well the Wells Fargo (NYSE: WFC) (Cramer's Take) and Morgan Stanley (NYSE: MS) (Cramer's Take) deals behaved, didn't you, as a bank player, have to presume that there would be and will be more offerings?

If Wells Fargo went up 6, isn't it reasonable to presume that Bank of New York Mellon (NYSE: BK) (Cramer's Take), KeyCorp (NYSE: KEY) (Cramer's Take), Capital One (NYSE: COF) (Cramer's Take), BB&T (NYSE: BBT) (Cramer's Take) and no doubt all of the others, would do the same? Who wouldn't take advantage of this? Fifth Third (NASDAQ: FITB) (Cramer's Take)? Suntrust (NYSE: STI) (Cramer's Take)?

Why did they rally so much?

Continue reading Cramer on BloggingStocks: A bevy of bank offerings

Analyst upgrades, downgrades and initiations: MS, BBC, DOW, COST, VLO, WSM ...

Analyst upgrades:

  • FBR Capital upgraded KBW, Inc (NYSE: KBW) to Market Perform from Underperform as it sees increased capital-raising opportunities for small and mid-sized banks and believes the company's quarter is off to a strong start. The firm raised its target price to $23 from $18.
  • Pali Capital upgraded Morgan Stanley (NYSE: MS) to Buy from Neutral on expectations the company's strategic shift towards advisory, distribution and retail will be monetized sooner than expected and its capital markets business is gaining traction. The firm set a $33 target on the stock.
  • Baird upgraded Stericycle (NASDAQ: SRCL) to Outperform from Neutral and raised its target to $58 from $55 based on valuation predictable earnings, and its market leading platform.
  • Apollo Investment (NYSE: AINV) was raised to Outperform from Market Perform at Keefe Bruyette.
  • HSBC Holdings (NYSE: HBC) was lifted at Goldman to Buy from Neutral.
  • Dow Chemical (NYSE: DOW) was upgraded to Outperform from Neutral at Credit Suisse.

Continue reading Analyst upgrades, downgrades and initiations: MS, BBC, DOW, COST, VLO, WSM ...

Dow Chemical to raise money - but not enough

Dow Chemical (DOW) is raising $1.63 billion by selling common stock. But it really needs more money than that. Perhaps in the current credit market the interest rate it would have had to pay on debt was simply too much.

Reportedly, $1 billion will be used to reduce debt it is taking on to buy rival Rohm and Hass. But the total purchase price of the transaction is $16.5 billion. Dow tried to get out of the deal. The margins in the chemical industry were ruined by the recession, but the document it signed with Rohm & Hass was airtight. Dow will almost certainly end up overpaying and will be burdened with a mammoth debt load in the process.

Continue reading Dow Chemical to raise money - but not enough

Earnings highlights: Starbucks, Kodak, Verizon, Visa, Office Depot, Baidu and more

Here are some highlights from this past week's earnings coverage from BloggingStocks:

Continue reading Earnings highlights: Starbucks, Kodak, Verizon, Visa, Office Depot, Baidu and more

Dow Chemical's profit drops 97% but tops expectations

When is a 97% drop in profit not necessarily a bad thing? Well, when the company still manages to top expectations of course. This unlikely scenario has unfolded for Michigan-based chemical firm Dow Chemical (NYSE: DOW).

Let's deal with the 97% profit drop first. This massive fall was triggered by falling sales, job cuts and the company's acquisition of Rohm & Haas, a specialty chemicals firm that Dow took over.

Continue reading Dow Chemical's profit drops 97% but tops expectations

Closing Bell: FASB says 'you bet your assets' (AMZN, BAC, C, DOW, MGM, DOW)

Stocks continued their fight higher today. The G-20 meeting yielded more talks of regulation, more aid for developing nations, and additional labor efforts globally. But the real boost was the end of "mark-to-market" accounting for the banks on illiquid debt assets. This sent the banks flying. Stocks which might have otherwise sold off even rallied on the surge today.

Here were today's unofficial closing bell levels:

Dow 7,978.08 +216.48 (2.79%)
S&P 500 834.38 +23.30 (2.87%)
Nasdaq 1,602.63 +51.03 (3.29%)

Top Analyst Upgrades
Top Analyst Downgrades

Continue reading Closing Bell: FASB says 'you bet your assets' (AMZN, BAC, C, DOW, MGM, DOW)

Dow Chemical (DOW) to sell Morton Salt for $1.675 billion

DOW logoDow Chemical (NYSE: DOW - option chain) shares are headed higher today after the company closed its acquisition of Rohm & Haas. This allows DOW to announce today it plans to sell Morton Salt to German company K+S Aktiengesellschaft for nearly $1.7 billion. This will help DOW stabilize its finances, which were left in a lurch when Kuwaiti financing on the Rohm & Haas deal fell through. Left out in the cold in this deal is Compass Minerals International (NYSE: CMP), a salt company that had been expected to get a bid from K+S. If you think that DOW won't fall by too much in the coming months, then now could be a good time to look at a bullish hedged trade on that stock.

DOW opened this morning at $9.46. So far today the stock has hit a low of $9.25 and a high of $9.75. As of 12:05, DOW is trading at $9.69, up 88 cents (10.0%). The chart for DOW looks neutral and S&P gives DOW a 3 STARS (out of 5) hold ranking.

Continue reading Dow Chemical (DOW) to sell Morton Salt for $1.675 billion

Closing Bell: Profit taking beats the bull (AGN, AIG, DOW, GS, LVS)

Today's lack of a rally came with little surprise. The massive gains yesterday were reminders of the panic buying seen in the past. Profit takers used the strength to unload on the new buyers who chased stocks yesterday.

Confusing housing data caused another brief hope because of an uptick, but that was following a downward revision. The Geithner-Bernanke testimony to Congress today did very little for the markets. Here were today's unofficial closing bell levels:

Dow 7,660.37 -115.49 (-1.49%)
S&P 500 806.37 -16.55 (-2.01%)
Nasdaq 1,518.70 -37.07 (-2.38%)

Top Analyst Upgrades & Downgrades

Continue reading Closing Bell: Profit taking beats the bull (AGN, AIG, DOW, GS, LVS)

Before the bell: Stocks set for a higher open on Citi, deals

Finally, a morning where stocks are set to bounce at the open as some positive signs pushed U.S. stock futures higher. As investors await Federal Reserve Chairman Bernanke's comments, there were some positive signs from the banking sector and on the deals front.

Citigroup (NYSE:C)'s Pandit said the bank was profitable during the first two months of the year. Also, Dow Chemical (NYSE: DOW) decided tentatively to go ahead with its acquisition of Rohm & Hass (NYSE: ROH) after all. There were also reports Genentech (NYSE: DNA) was on the verge of being fully acquired -- all coming a day after the mega-deal between Merck (NYSE: MRK) and Schering Plough (NYSE: SGP).

Continue reading Before the bell: Stocks set for a higher open on Citi, deals

Dow Chemical, Rohm & Haas make nice in a $15 billion deal

With litigation, it seems that the winners are usually the attorneys. Perhaps this is one of the key reasons that Dow Chemical (NYSE: DOW) and Rohm and Haas Co (NYSE: ROH) agreed to come back to the table and find a way to strike a merger. If not, both parties were on a destructive path to an unpredictable trial.

Interestingly enough, the new terms of the deal reinstate the $78 purchase price, but, of course, there are some wrinkles. The Haas Family Trust and Paulson & Co. will get as much as $3 billion preferred stock in Dow. This will be a much-needed infusion of capital.

Continue reading Dow Chemical, Rohm & Haas make nice in a $15 billion deal

Today's technical outlook: Market building the case for capitulation

I wrote yesterday about the current, relatively low level of the CBOE Volatility Index (VIX), comparing it to the 2002 -2003 triple-bottom. I concluded that low levels after a bear market could indicate that a capitulation had occurred.

There was more evidence of that yesterday.

When the market opened sharply lower, the VIX opened very close to its intra-day high but sharply reversed and closed the day just .68 higher at 45.52. And the Dow and the S&P 500 traded fractionally lower.

This week should flush out most of any remaining bad earnings news with some very big names, such as Dow Chemical (NYSE: DOW), Disney (NYSE: DIS), Merck (NYSE: MRK) and Motorola (NYSE: MOT) reporting today.

Continue reading Today's technical outlook: Market building the case for capitulation

Stocks in the news: SNDK, DOW, BP, VOD, MRK, MOT, M, F, GM ...

Ford (NYSE: F) and General Motors (NYSE: GM) are among the many car companies to report January sales today, with estimates calling for declines of possibly over 40%.

SanDisk (NASDAQ: SNDK) posted a huge fourth-quarter net loss of $1.9 billion Monday after the close. While some of the loss was attributed to a $2 billion one-time charge, weak consumer spending and pricing pressures in the memory chip market also took their toll. Sandisk's adjusted net loss was $1.65 a share; Revenue was $863.9 million, down from $1.25 billion last year. Analysts had expected a net loss of 60 cents a share, on revenue of $766.7 million, according to Thomson Reuters. SNDK shares sank over 20% in premarket trading.

Continue reading Stocks in the news: SNDK, DOW, BP, VOD, MRK, MOT, M, F, GM ...

Dow Chemical's botched M&A experiment

Back in July, Dow Chemical Co. (NYSE: DOW) agreed to pay $15.4 billion for Rohm & Haas Co. (NYSE: ROH), a top specialty chemicals operator. At the time, it looked like a sign that confidence was coming back into the system.

But, of course, the smart money was proved wrong – once again -- as the deal fell apart. So, this week Rohm & Haas has filed a suit against Dow to force the deal to happen. You see, the deal was supposed to close Monday.

The legal action rattled investors: On Monday, Dow's stock fell 7.61% to $13.24 and Rohm & Haas' stock was down 13.25% to $57.10.

Continue reading Dow Chemical's botched M&A experiment

Dow Chemical (DOW) getting sued, watch out below

At just over $13, Dow Chemical (NYSE:DOW) is already trading near its 52-week low. The shares may go lower. Rohm & Haas (NYSE:ROH), which is being bought by Dow, is suing to get the deal finished.

According to Dow Jones, "Dow confirmed that it doesn't intend to close the merger by a Tuesday deadline, with Chief Executive Andrew Liveris calling the deal 'untenable at this time' in a prepared statement. "

Dow is in a pinch. A joint venture with Kuwait, which should have brought in billions of dollars, was canceled. And, banks are not likely to lend money for most M&A deals. Private equity firms have shut off almost all of their investment activity.

Continue reading Dow Chemical (DOW) getting sued, watch out below

Caterpillar job cuts show economy's scary turn

Caterpillar Inc. (NYSE: CAT) today announced that it would slash 20,000 jobs as the boom in ethanol production that fueled the company's growth is turning into a bust. Earnings at the farm and heavy-machinery equipment maker also will trail analysts' forecasts.

But wait. There's more.

Home Depot Inc.
(NYSE: HD), whose reputation suffered under the leadership of former CEO Robert Nardelli, will slash 7,000 jobs and exit the EXPO business. I am sure this won't make workers at Nardelli's current employer Chrysler LLC feel too good. Sprint Nextel Corp. (NYSE: S), whose troubles pre-date the economic slump, is firing 8,000 workers as it seeks to lower its expenses by $1.2 billion.

Thousands more jobs will be axed in the Pfizer Inc.'s (NYSE: PFE) $68 billion acquisition Wyeth (NYSE: WYE). Who knows how many employees will get chopped now that the Dow Chemical Co. (NYSE: DOW) purchase of Rohm & Haas Co. (NYSE: ROH) will not take place. Let's not forget Starbucks Corp. (NASDAQ: SBUX), which reportedly is firing 1,000 workers at its corporate headquarters.

Continue reading Caterpillar job cuts show economy's scary turn

Next Page »

Symbol Lookup
IndexesChangePrice
DJIA-223.328,280.74
NASDAQ-49.201,796.52
S&P 500-26.91896.42

Last updated: July 04, 2009: 10:10 AM

BloggingStocks Exclusives

Hot Stocks

DailyFinance Headlines

Latest from BloggingBuyouts

AOL Business News

BioHealth Investor Headlines

Sponsored Links

My Portfolios

Track your stocks here!

Find out why more people track their portfolios on AOL Money & Finance then anywhere else.

BloggingStocks Partners

More from AOL Money & Finance